A

Anatara Lifesciences
ANR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$1.49M
EV
A$391.97K
Shares Outstanding
213.38M
Beta
0.57

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2020E
-
P/Revenue 2020E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Anatara Lifesciences Ltd

gainify

A

Anatara Lifesciences Ltd

ANR

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. The company offers Gastrointestinal ReProgramming, a proprietary formulation to address i...

Sector

Healthcare

Industry

Biotechnology

CEO

Brookes, David

Employees

IPO Date

2014-10-15

Headquarters

81 Flinders Street, Level 8, Adelaide, South Australia, 5000, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.